Yaron Werber
Stock Analyst at TD Cowen
(1.54)
# 3,457
Out of 5,044 analysts
39
Total ratings
38.46%
Success rate
-3.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Downgrades: Hold | n/a | $1.50 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.91 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $315.43 | +5.89% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $13.00 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $33.52 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $22.62 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $203.23 | -24.72% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $106.05 | +15.04% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $23.58 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $35.31 | +106.74% | 2 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $34 | $39.99 | -14.98% | 2 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $59 | $72.99 | -19.17% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $32.12 | +108.59% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $33.00 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.33 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.30 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $27.37 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $829.83 | -22.76% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.00 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $10.94 | +5,612.98% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.87 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $29.03 | +30.90% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $18.81 | - | 1 | Oct 26, 2021 |
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.50
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.91
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $315.43
Upside: +5.89%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $13.00
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $33.52
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $22.62
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $203.23
Upside: -24.72%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $106.05
Upside: +15.04%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $23.58
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $35.31
Upside: +106.74%
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $39.99
Upside: -14.98%
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $72.99
Upside: -19.17%
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $32.12
Upside: +108.59%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $33.00
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.33
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $6.30
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $27.37
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $829.83
Upside: -22.76%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $6.00
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $10.94
Upside: +5,612.98%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $19.87
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $29.03
Upside: +30.90%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $18.81
Upside: -